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Human T-cell leukemia virus type 1 (HTLV-1) is the etiological agent of adult T cell
leukemia (ATL), which is an aggressive form of T-cell malignancy. HTLV-1 onco-
proteins, Tax and HBZ, play crucial roles in the immortalization of T-cells and ⁄ or
leukemogenesis by dysregulating the cellular functions in the host. Recent stud-
ies show that HTLV-1-infected T-cells have reduced expression of the BCL11B
tumor suppressor protein. In the present study, we explored whether Tax and ⁄ or
HBZ play a role in downregulating BCL11B in HTLV-1-infected T-cells. Lentiviral
transduction of Tax in a human T-cell line repressed the expression of BCL11B at
both the protein and mRNA levels, whereas the transduction of HBZ had little
effect on the expression. Tax mutants with a decreased activity for the NF-jB,
CREB or PDZ protein pathways still showed a reduced expression of the BCL11B
protein, thereby implicating a different function of Tax in BCL11B downregula-
tion. In addition, the HTLV-2 Tax2 protein reduced the BCL11B protein expression
in T-cells. Seven HTLV-1-infected T-cell lines, including three ATL-derived cell
lines, showed reduced BCL11B mRNA and protein expression relative to an unin-
fected T-cell line, and the greatest reductions were in the cells expressing Tax.
Collectively, these results indicate that Tax is responsible for suppressing BCL11B
protein expression in HTLV-1-infected T-cells; Tax-mediated repression of BCL11B
is another mechanism that Tax uses to promote oncogenesis of HTLV-1-infected
T-cells.
H uman T-cell leukemia virus type 1 (HTLV-1) is a causa-tive agent of adult T-cell leukemia (ATL), which is char-
acterized as an aggressive mature T-cell leukemia. HTLV-1 has
two oncoproteins, Tax and HTLV-1 bZIP factor (HBZ), both of
which play crucial roles in persistent HTLV-1 infection and
leukemogenesis.(1–3) Tax by itself immortalizes primary human
T-cells in vitro, and tax-transgenic mice develop various malig-
nancies, including mature T-cell leukemia. To achieve these
effects, Tax interacts with several cellular proteins involved in
cell cycle regulation,(4,5) apoptosis,(6) genomic instability(7,8)
and DNA repair,(6) and modulates their functions. For instance,
Tax interacts with various transcription regulatory factors,
including cAMP-responsive element-binding protein ⁄ activating
transcription factor (CREB ⁄ATF) and IKK, through which Tax
activates the expression of a number of cellular genes.
Unlike Tax, HBZ is dispensable for T-cell immortalization
by HTLV-1, but it was required for persistent HTLV-1
infection in an in vivo animal model.(9) In addition, HBZ-
transgenic mice develop mature T-cell lymphoma.(10) HBZ
also has multiple activities. For example, HBZ prevents apop-
tosis by promoting the anti-apoptotic function of FoxO3a.(11)
HBZ upregulates the expression of the hTERT telomerase sub-
unit gene,(12) and inhibits the transcriptional activation of
cellular genes mediated by c-Jun, CREB ⁄ATF and RelA.(13–15)
BCL11B is a transcriptional regulatory protein containing
C2H2-type zinc fingers, and it is required for normal T-cell
development.(16) Moreover, BCL11B has been shown to act as a
tumor suppressor gene in T-cell acute lymphoblastic leukemia
(T-ALL). Genetic alterations of BCL11B, such as by chromo-
somal rearrangements, have been identified in several T-ALL
patients.(17) Intriguingly, HTLV-1-infected T-cells, including
ATL cells, have been reported to have reduced BCL11B protein
expression,(18) but the mechanism remains to be elucidated. In
the present study, we show that the HTLV-1 oncoprotein Tax is
sufficient to downregulate BCL11B expression in T-cells.
Materials and Methods
Cell lines and culture condition. SLB-1, HUT-102, MT-2 and
MT-4 are HTLV-1-transformed human T-cell lines. TL-OmI,
KK-1 and KOB are HTLV-1-positive ATL patient-derived cell
lines. Jurkat and MOLT-4 are HTLV-1-negative T-cell lines.
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These human T-cell lines were cultured in RPMI1640 medium
supplemented with 10% FBS, 4 mM L-glutamine and antibiot-
ics (RPMI ⁄10%FBS). Recombinant human IL-2 (Takeda
Chemical Industries, Osaka, Japan) was added at 0.5 nM to
the cultures of KK-1 and KOB cells. 293T cells, which are
highly transfectable kidney-derived cells, were cultured in
DMEM supplemented with 10% FBS, 4 mM L-glutamine and
antibiotics.
Plasmids. CSII-EF-Tax-IRES and CSII-EF-Tax-IRES-sHBZ
were the IRES-mediated bicistronic lentiviral vectors for Tax
and Tax together with spliced-HBZ (sHBZ), respectively.
CSII-EF-IRES-GFP was used as a control vector. The lentivi-
ral expression vectors for HTLV-1 Tax, its mutants (TaxDC,
TaxM22, Tax703, Tax[225–232]) and HTLV-2 Tax2B have
been described previously.(19,20) Tax(TTG) has a mutation
from A to T at the initiation codon of tax gene, and, thus, it
expresses the Tax transcript, but not its protein. Tax(TTG)
cDNA was constructed by introducing mutation with the PCR.
Next, the Tax(TTG) cDNA was cloned into the pENTR ⁄
D-TOPO plasmid (Invitrogen, Carlsbad, CA, USA), and then
the cDNA was transferred into lentiviral vector CSII-EF-IRES-
GFP-RfA(20) through an LR recombination reaction using LR
clonase (Invitrogen). The expression vector pHbPr-1-neo was
used for the transient expression of Tax, Tax2B and its mutant
proteins (TaxDC, TaxM22, Tax703) in Jurkat cells in order to
perform a lucifearase assay as described previously.(21,22) Tax
(225–232) protein is defective for the activation of the non-
canonical NF-jB ⁄p100 ⁄p52 pathway, but it is active for the
canonical NF-jB pathway,(19) and the expression vector was
constructed by inserting the Tax(225–232) gene into the
expression vector pHbPr-1-neo. The transcriptional activity
reporter plasmids, jB-luc, CRE-luc and pGK ⁄b-gal, have all
been described previously.(22,23)
Lentivirus transduction. Recombinant lentiviruses were gener-
ated by transfecting pCAG-HIVgp, pCMV-VSV-G-RSV-Rev
and the respective lentiviral vectors into 293T cells using
FuGENE HD (Roche Diagnostic, Mannheim, Germany). Sev-
enty-two hours after transfection, the culture supernatants were
harvested, and were infected into Jurkat or MOLT-4 cells
(4 9 105) at a final volume of 2 mL of RPMI ⁄10%FBS con-
taining 8 lg ⁄mL polybrene.
Quantitative real-time RT-PCR. Total RNA was isolated from
cells using the NucleoSpin RNA II Kit (MACHEREY-NA-
GEL; TaKaRa, Shiga, Japan), and RNA was reverse-tran-
scribed using the PrimeScript RT reagent kit (TaKaRa).
BCL11B cDNA fragments were amplified and analyzed by the
real-time PCR assay performed using SYBR Green Real-Time
PCR Mix (TOYOBO, Osaka, Japan) with a 25 lL reaction
volume. The quantity of BCL11B mRNA was normalized to
the quantity of GAPDH mRNA.
Western blot analysis. The western blot analyses were carried
out as described previously.(24) The primary antibodies used at
the indicated dilutions were anti-BCL11B (1 ⁄1000),(16)
anti-BCL11B (1 ⁄1000) (Cell Signaling Technology, Beverly,
MA, USA), anti-Tax (1 ⁄ 2000) (Taxy7),(25) anti-Tax2,(26) anti-
a-tubulin (DM1A) (1 ⁄1000) (Calbiochem, San Diego, CA,
USA) and a-HBZ (1 ⁄1000).(9) Horseradish peroxidase (HRP)-
conjugated rat anti-mouse IgG kappa light chain (BD
Biosciences, San Jose, CA, USA) and HRP-conjugated goat
anti-rabbit IgG (sc-2054; Santa Cruz Biotechnology, Santa
Cruz, CA, USA) were used as secondary antibodies (1
⁄10 000). Immunoreactive bands were visualized with the
Enhanced Chemiluminescence Detection System (Amersham
Pharmacia Biotech, Orsay, France).
Luciferase assay. Jurkat cells (2.0 9 105) in 12-well plates
were cotransfected with the expression vector pHbPr-1-neo
encoding Tax, TaxDC, TaxM22, Tax703, Tax(225-232) or
Tax2B, together with pGK ⁄b-gal and either jB-luc or CRE-
luc using TransFectin (Bio-Rad Technologies) according to the
manufacturer’s instructions. At 48 h after transfection the cell
lysates were prepared, and the luciferase and b-galactosidase
activities in the lysates were measured using both the Lucifer-
ase Assay System (Promega, Fitchburg, WI, USA) and the
Galacto-Light System (Applied Biosystems, Foster City, CA,
USA), respectively.
Statistical analysis. Differences in the gene expression levels
between the cell lines were analyzed using unpaired Student’s
t-tests, and were presented as the means  SD.
Results
Kurosawa et al.(18) showed that the BCL11B expression lev-
els in HTLV-1-infected cells were downregulated relative to
those in HTLV-1-infected cells. To elucidate the mechanism
responsible for this, we measured the expression of BCL11B
in various human T-cell lines, including HTLV-1-trans-
formed and ATL-derived cell lines by performing western
blot analyses and RT-PCR assays. Consistent with the previ-
ous study, the amounts of BCL11B protein and mRNA in
the HTLV-1-transformed and ATL-derived cell lines were
lower than those in HTLV-1-uninfected cell lines (Fig. 1).
The extent of BCL11B mRNA downregulation in HTLV-1-
transformed cells, except for the MT-4 cells, was higher
than that in the ATL cells. While the ATL-derived cells
expressed the HBZ protein at a level equivalent to that in
HTLV-1-transformed cells, they expressed no or very little
Tax protein (Fig. 1a), which is typical of ATL-derived cell
lines. Therefore, the present results indicate that Tax, either
alone or together with HBZ, regulates BCL11B expression
in HTLV-1-infected cells.
To assess this possibility, we transiently expressed Tax and
the spliced form of HBZ (sHBZ) in an HTLV-1-uninfected
T-cell line (Jurkat) expressing a relatively high amount of
BCL11B by using lentiviral vectors (Fig. 2a,b). Tax reduced
the amount of BCL11B protein in the Jurkat cells (Fig. 2b),
whereas sHBZ had little effect on its expression amount
(Fig. 2a). Tax also reduced the amount of BCL11B protein in
another human T-cell line, MOLT-4 (Fig. 2c). The RT-PCR
analysis elucidated that Tax represses BCL11B expression at
the mRNA level in Jurkat cells (Fig. 2d). These results
indicated that Tax represses the expression of BCL11B in
HTLV-1-infected T-cells.
To explore the mechanism by which Tax regulates BCL11B
repression, we transiently expressed several Tax mutants in
Jurkat cells using lentiviral vectors. Similar to the results
obtained for wild type Tax, four Tax mutants (TaxDC,
TaxM22, Tax703 and Tax[225–232]) reduced the expression
of the BCL11B protein in Jurkat cells, whereas Tax(TTG), a
Tax mutant without an initiation codon, did not show such
reduction. Moreover, HTLV-2 Tax2 also reduced the expres-
sion of the BCL11B protein. A luciferase reporter assay
showed that Tax, TaxDC and Tax(225–232) equivalently acti-
vated the promoter activity under the control of jB-enhancer
as well as the CRE (c-AMP responsive element) enhancer in
the HTLV-1 promoter (Fig. 3c,d). In contrast, TaxM22 only
slightly stimulated the NF-jB-dependent transcription. Tax703
activated CRE, but it was less effective than Tax. It should
also be noted that Tax(225–232) has a selective defect for non-
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canonical jB-dependent transcriptional activation,(19) and
TaxDC has a deletion of the PDZ-domain binding motif
(PBM).(27) These results suggested that the jB-dependent and
CRE-dependent transcriptional activation, as well as PBM-
mediated signaling of Tax, are dispensable for the repression
of BCL11B.
Discussion
The previous study showed that both HTLV-1-transformed T-
cells and ATL-derived cell lines have reduced expression of
BCL11B.(18) In this study, we found that Tax is a major factor
associated with the BCL11B downregulation in HTLV-1-trans-
formed T-cells, and this downregulation mainly occurred at the
transcriptional level. Together with the known roles of
BCL11B in normal T-cell development and as a tumor
suppressor in T-cell leukemia, the present study suggests that
the downregulation of BCL11B by Tax plays a role in T-cell
transformation by HTLV-1 and persistent HTLV-1 infection.
How does the Tax-induced downregulation of BCL11B alter
the phenotypes of HTLV-1-infected cells? Kurosawa et al.(18)
showed that the exogenous expression of BCL11B in two
ATL-derived cell lines reduced their growth, but the expres-
sion did not affect the growth of Jurkat cells (a reduced level
of the BCL11B protein is associated with adult T-cell leuke-
mia ⁄ lymphoma). These results suggest that the downregulation
of BCL11B can specifically promote the growth of HTLV-1-
infected cells.
Like HTLV-1 Tax, the HTLV-2 Tax2 protein repressed the
expression of the BCL11B protein (Fig. 3a). Tax2 is essential
for the immortalization of primary human T-cells by HTLV-2
in vitro.(28) Thus, the BCL11B repression by Tax2 proteins
may also play a role in HTLV-2 immortalization of T-cells.
Tax and Tax2 share many activities, including NF-jB
(b)(a)
Fig. 1. The downregulation of BCL11B expression
in HTLV-1-infected T-cell lines. (a) Cell lysates were
prepared from the indicated human T-cell lines,
and the expression levels of BCL11B, Tax, HBZ and
a-tubulin in the cell lysates were measured by
western blot analysis. (b) Total RNA was prepared
from the indicated human T-cell lines, and the
amounts of BCL11B mRNA were measured by
quantitative real-time RT-PCR. The quantity of
BCL11B mRNA was normalized to the quantity of
GAPDH mRNA. *P < 0.05. ATL, adult T cell
leukemia; HTLV-1, human T-cell leukemia virus




Fig. 2. Tax represses BCL11B expression in T-cells.
(a–c) Cell lysates were prepared from Jurkat (a, b)
or MOLT-4 cells (c) infected with the indicated
lentiviruses, and the expression of BCL11B, Tax, HBZ
and a-tubulin in the cell lysates was examined by
western blot analysis. A lentivirus expressing the
GFP protein (GFP) was used as a control. (d) Total
RNA was prepared from Jurkat cells infected with
the indicated lentiviruses, and the amounts of
BCL11B mRNA in the cells were measured by
quantitative real-time RT-PCR. The quantity of
BCL11B mRNA was normalized to the quantity of
GAPDH mRNA. **P < 0.01; ***P < 0.001. NS, not
significant.
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activation.(29) The four Tax mutants examined herein still
repressed the expression of the BCL11B protein in T-cells
(Fig. 3). Therefore, a further analysis is required to determine
how Tax represses the expression of BCL11B in T-cells.
The BCL11B gene shows T lineage-specific expression,
including CD4-positive T cells. Li et al.(30) identified the long-
range tissue-specific transcriptional regulatory elements in the
BCL11B gene, and showed that both the promoter region con-
taining a transcription initiation site and the 1.9 kb region
850 kb downstream of the BCL11B gene are required for T
lineage-specific expression. The 1.9 kb region in the BCL11B
gene contained several putative transcription factor binding
sites, and these TCF-1 binding sites were required for the T
lineage-specific expression of BCL11B in the reporter assay.
While the three ATL cell lines possessed reduced amounts
of BCL11B expression, one out of three ATL cell lines
expressed a low amount of Tax protein, indicating that the
downregulation of BCL11B expression in ATL cells is gener-
ally Tax-independent. Kurosawa et al.(18) failed to detect DNA
methylation of the BCL11B locus. Therefore, the mechanism
underlying BCL11B downregulation in ATL cells remains to
be elucidated.
Several leukemogenic events have been shown to be initially
set in motion by Tax in HTLV-1-infected cells in vivo, but
once such cells become transformed, then a Tax-independent
mechanism may subsequently continue the leukemic process.
For instance, primary ATL cells and ATL-derived cell lines
without Tax expression demonstrate constitutive NF-jB activa-
tion, which is critical for the growth of leukemic cells and is a
later stage step in the development of leukemia. Therefore, the
downregulation of BCL11B by Tax in HTLV-1-infected cells
sets the stage for development of ATL. Our data reveal a
novel mechanism of Tax in repressing the expression of a
tumor suppressor, BCL11B, in order to promote the continuous
proliferation of HTLV-1-infected cells. Taken together, our
findings support the idea that the downregulation of BCL11B
plays a role in ATL development.
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